Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemia

Co-expression analysis reveals useful dysregulation patterns of gene cooperativeness for understanding cancer biology and identifying new targets for treatment. We developed a structural strategy to identify co-expressed gene networks that are important for chronic myelogenous leukemia (CML). This strategy compared the distributions of expressional correlations between CML and normal states, and it identified a data-driven threshold to classify strongly co-expressed networks that had the best coherence with CML. Using this strategy, we found a transcriptome-wide reduction of co-expression connectivity in CML, reflecting potentially loosened molecular regulation. Conversely, when we focused on nucleophosmin 1 (NPM1) associated networks, NPM1 established more co-expression linkages with BCR-ABL pathways and ribosomal protein networks in CML than normal. This finding implicates a new role of NPM1 in conveying tumorigenic signals from the BCR-ABL oncoprotein to ribosome biogenesis, affecting cellular growth. Transcription factors may be regulators of the differential co-expression patterns between CML and normal.

[1]  A. Bishayee,et al.  Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. , 2009, Chemico-biological interactions.

[2]  R. Fisher.  On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .

[3]  D. Gutmann,et al.  TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation. , 2007, Cancer research.

[4]  Jun Dong,et al.  Geometric Interpretation of Gene Coexpression Network Analysis , 2008, PLoS Comput. Biol..

[5]  Lynne M Connelly,et al.  Fisher's Exact Test. , 2016, Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses.

[6]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[7]  M. Gerstein,et al.  Genomic analysis of gene expression relationships in transcriptional regulatory networks. , 2003, Trends in genetics : TIG.

[8]  R. Fisher.  On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2018, Journal of the Royal Statistical Society Series A (Statistics in Society).

[9]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[11]  E. S. Pearson.  Biometrika tables for statisticians , 1967 .

[12]  Beau Dabbs,et al.  Summary and discussion of : “ Controlling the False Discovery Rate : A Practical and Powerful Approach to Multiple Testing , 2014 .

[13]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[14]  Y. Yen,et al.  Mechanistic Control of Carcinoembryonic Antigen-related Cell Adhesion Molecule-1 (CEACAM1) Splice Isoforms by the Heterogeneous Nuclear Ribonuclear Proteins hnRNP L, hnRNP A1, and hnRNP M* , 2011, The Journal of Biological Chemistry.

[15]  Christina Kendziorski,et al.  Statistical methods for gene set co-expression analysis , 2009, Bioinform..

[16]  B. Druker.  Overcoming resistance to imatinib by combining targeted agents. , 2003, Molecular cancer therapeutics.

[17]  Antonio Reverter,et al.  A Differential Wiring Analysis of Expression Data Correctly Identifies the Gene Containing the Causal Mutation , 2009, PLoS Comput. Biol..

[18]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[19]  Hiromitsu Araki,et al.  GeneSetDB: A comprehensive meta-database, statistical and visualisation framework for gene set analysis , 2012, FEBS open bio.

[20]  H. Hotelling.  New Light on the Correlation Coefficient and its Transforms , 1953 .

[21]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Pandolfi,et al.  Nucleophosmin Serves as a Rate-Limiting Nuclear Export Chaperone for the Mammalian Ribosome , 2008, Molecular and Cellular Biology.

[23]  K. Lange,et al.  Genetics of early-onset obsessive–compulsive disorder , 2010, European Child & Adolescent Psychiatry.

[24]  Y. Baran,et al.  Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells. , 2012, Anticancer research.

[25]  Magdalena Szumilas.  Explaining odds ratios. , 2010, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[26]  Dan A. Biddle,et al.  Using Lancaster's mid-P correction to the Fisher's exact test for adverse impact analyses. , 2011, The Journal of applied psychology.

[27]  Sameer Al-harthi,et al.  Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line , 2012, Cancer Cell International.

[28]  Marcio Luis Acencio,et al.  The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Mathieu Blanchette,et al.  PReMod: a database of genome-wide mammalian cis-regulatory module predictions , 2006, Nucleic Acids Res..

[30]  Antonio Marco,et al.  Relationship between gene co-expression and sharing of transcription factor binding sites in Drosophila melanogaster , 2009, Bioinform..

[31]  B. Brors,et al.  Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase , 2007, Leukemia.

[32]  Daniela Cilloni,et al.  Molecular Pathways: BCR-ABL , 2011, Clinical Cancer Research.

[33]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[34]  Y. Liu,et al.  B23 acts as a nucleolar stress sensor and promotes cell survival through its dynamic interaction with hnRNPU and hnRNPA1 , 2010, Oncogene.

[35]  Pier Paolo Pandolfi,et al.  Nucleophosmin and cancer , 2006, Nature Reviews Cancer.

[36]  Dong Xu,et al.  Pathway Correlation Profile of Gene-Gene Co-Expression for Identifying Pathway Perturbation , 2012, PloS one.

[37]  Matej Oresic,et al.  Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process , 2007, Bioinform..

[38]  S. Horvath,et al.  Weighted gene coexpression network analysis strategies applied to mouse weight , 2007, Mammalian Genome.

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[40]  Homin K. Lee,et al.  Coexpression analysis of human genes across many microarray data sets. , 2004, Genome research.

[41]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.